Influence of propranolol, pindolol, practolol and talinolol on arachidonic acid (AA)- and U-46619-induced aggregation and on AA-induced thronboxane A2 formation in platelets

This publication has 26 references indexed in Scilit:

• ANTI-PLATELET ACTIVITY OF BETA-ADRENERGIC ANTAGONISTS: INHIBITION OF THROMBOXANE SYNTHESIS AND PLATELET AGGREGATION IN PATIENTS RECEIVING LONG-TERM PROPRANOLOL TREATMENT
  The Lancet, 1981
• Differential effects of local anesthetics and propranolol on arachidonic acid and adenosine 5′-diphosphate-induced aggregation in rabbit platelets
  Prostaglandins and Medicine, 1980
• Platelet aggregation in aortic and coronary venous blood in patients with and without coronary disease. 3. Role of tachycardia stress and propranolol.
  Circulation, 1978
• Effects of propranolol and pindolol on platelet aggregation and serotonin release
  Life Sciences, 1977
• Effect of propranolol on platelet function
  Blood, 1977
• Reversal of Abnormal Platelet Aggregability and Change in Exercise Tolerance in Patients with Angina Pectoris Following Oral Propranolol
  Circulation, 1974
• β-Blocking Agents and Platelet Aggregation
  Published by American Medical Association (AMA) ,1974
• Platelet Function Studies in Coronary Artery Disease
  Circulation, 1973
• Platelet and Fibrinogen Consumption in Man
  New England Journal of Medicine, 1972
• Coagulation Tests and Platelet Economy in Atherosclerotic and Control Subjects
  Circulation, 1962